Target Entity:
Rainbow Women & Children's Hospital Private Limited (RWCHPL)
Type of Deal:
Induction of a strategic partner (Fountainhead TCHM Healthcare LLP) into a wholly-owned subsidiary for a brownfield capacity addition project. This constitutes a joint venture.
Stake/Capacity:
Fountainhead TCHM Healthcare LLP is proposed to acquire a 24% equity stake in RWCHPL. The project involves the development of a new 100-bed children and women's hospital.
Deal Value:
The total estimated project cost is approximately ₹90 Crore. Rainbow Children's Medicare Limited (RCML) will contribute ₹68.40 Crore to its subsidiary RWCHPL for this project.
Funding Source:
The investment will be funded through Internal Accruals.
Financial Impact:
The subsidiary, RWCHPL, had a negligible financial contribution in the previous year. Its turnover for FY 2025-26 was Nil and its net worth as of March 31, 2026, was ₹ (0.003) Crore. The financial impact of the new hospital on future revenue and profitability is not explicitly disclosed in the document.
Timeline:
The transaction for the induction of the LLP is expected to be completed on or before August 31, 2026. The proposed 100-bed hospital capacity is expected to be commissioned by Q1 of FY 2027-28 (Q1 FY28), subject to receipt of necessary approvals and completion of construction.
Strategic Rationale:
The capacity addition will enhance the Company's ability to deliver specialized pediatric, women, and neonatal care across Maharashtra. The 100-bed brownfield hospital in Malad, Mumbai complements a previously announced 150-bed regional hub in Pune (expected FY29). Together, these facilities are intended to establish a strong regional hub-and-spoke network across Maharashtra, expanding the company's presence in Western India, improving patient access, strengthening referral pathways, and creating a scalable platform for long-term growth.
Approval Status:
The definitive transaction documents, including a Shareholders' Agreement, have been executed. The announcement is a regulatory intimation of this execution.
Reference Regulation:
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30 read with Schedule III and the SEBI Master Circular dated January 30, 2026.